R. Nejat, “Losartan Inhibits SARS-CoV-2 Replication in Vitro: Losartan promotes cell survival following SARS-CoV-2 infection in vitro”, J Pharm Pharm Sci, vol. 24, no. 3, pp. 390–399, Jul. 2021.